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Abstract
Purpose:  To  compare  the  efficacy  of  epithelium-off  corneal  collagen  crosslinking  (CXL)  with
transepithelial  CXL  in  patients  with  progressive  keratoconus  with  a  follow-up  of  3  years,  taking
into account  the  patients’  age  and  the  location  of  the  corneal  ectasia.
Methods:  In  this  prospective  study  participated  64  eyes  with  progressive  keratoconus  were
included in  this  long-term  study,  of  which  31  eyes  were  treated  by  epithelium-off  CXL  and
33 by  transepithelial  CXL.  All  of  the  patients  with  a  follow-up  of  36  months  were  evaluated
for visual  variables  (corrected  distance  visual  acuity  (CDVA),  corneal  aberrations,  and  corneal
densitometry),  structure  variables  (astigmatism,  keratometry,  corneal  asphericity,  maximum
posterior elevation,  corneal  thickness,  and  corneal  volume),  and  keratoconus  index  variables.
Results:  After  corneal  CXL,  CDVA  improved  significantly  in  both  central  and  paracentral  kera-
toconus,  with  greater  improvement  in  the  centrals  (p  =  0.001),  asphericity  at  6  mm  improved
in central  keratoconus  (p  =  0.047).  In  the  epi-off  group,  there  was  a  significant  improvement
in coma-like  (p  =  0.038),  higher-order  aberrations  (p  =  0.036),  asphericity  at  8  mm  (p  =  0.049),
asphericity  at  10  mm  (p  =  0.049),  and  index  of  surface  variance  (p  =  0.049).Please  cite  this  article  in  press  as:  Arance-Gil  Á,  et  al.  Epithelium-Off  vs.  transepithelial  corneal  collagen  crosslinking  in
progressive  keratoconus:  3  years  of  follow-up.  J  Optom.  (2020),  https://doi.org/10.1016/j.optom.2020.07.005
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Conclusion:  Although  both  techniques  halted  and  stabilized  the  progression  of  keratoconus,
epithelium-off  CXL  was  more  effective.  In  addition,  after  the  corneal  CXL,  there  was  a  greater
degree of  regularization  of  the  corneal  surface  and,  therefore,  a  greater  improvement  in  the
CDVA with  central  keratoconus  than  with  paracentral  keratoconus.
© 2020  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Patients  who  used  contact  lenses  were  instructed  to
discontinue  their  use  7--10  days  prior  to  treatment.  The  loca-ntroduction
eratoconus  (KC)  is  a  bilateral  and  generally  asymmetric
ctopic  corneal  disorder  that  induces  a  progressive  thinning
f  the  cornea  that  gives  rise  to  its  protrusion.  This  results
n  irregular  astigmatism  and,  in  the  late  stages,  corneal
brosis  with  substantial  visual  impairment.  It  is  usually  diag-
osed  during  puberty,  with  a  very  variable  and  unpredictable
rogression  rate  between  patients,  progressing  for  up  two
ecades  following  presentation.1
Currently,  non-surgical  treatments  for  KC  range  from  cor-
ective  glasses  for  the  most  incipient  grades,  to  contact
enses  for  moderate  and  advanced  stages.2 There  are,  how-
ver,  other  therapeutic  options  for  progressive  KC,  either
nvolving  the  addition  of  tissue,  as  is  the  case  with  intrastro-
al  ring  implants,  or  photochemical  treatments  such  as
orneal  collagen  cross-linking  (CXL)  with  riboflavin  (RF)  and
ltraviolet  A  (UVA)  radiation.  The  main  objective  of  the  lat-
er  treatment  option  is  to  halt  or  reduce  the  progression  of
ctasia,  thereby  avoiding  or  delaying  the  need  for  a  corneal
ransplant.3
In  2003,  Wollensak  et  al.  introduced  corneal  CXL,  which
s  one  of  the  most  promising  procedures  for  halting  pro-
ression  of  this  disease,  as  it  strengthens  the  cornea  by
ncreasing  the  cross-linking  of  collagen  fibers,  which  in  turn
ncreases  corneal  rigidity,  thereby  reducing  the  morbidity  of
he  disease  and  decreasing  or  delaying  the  need  for  a  corneal
ransplant.3
Standard  corneal  cross-linking  or  epithelium-off  CXL  (epi-
ff  CXL)  requires  removal  of  the  corneal  epithelium  prior
o  impregnation  of  the  cornea  with  RF  and  its  irradiation
or  30  min  with  ultraviolet  A  light  (UV-A).  Numerous  studies
ave  documented  its  safety  and  efficiency,4 and  there  have
een  publications  reporting  outcomes  using  this  technique
t  more  than  10  years  of  follow-up.5
However,  this  technique  includes  removal  of  the  epithe-
ium,  which  can  result  in  postoperative  pain  and  act  as  a
otential  source  of  complications  (e.g.,  infectious  keratitis,
terile  infiltrates,  and  corneal  haze).6
With  the  introduction  of  transepithelial  corneal  cross-
inking  (TE-CXL),  removal  of  the  corneal  epithelium  can  be
voided  and,  therefore,  also  the  associated  inconveniences
nd  complications.  There  has  been  an  increasing  number  of
ublished  studies  evaluating  the  therapeutic  effects  of  TE-
XL.  Recent  studies  have  suggested  that  TE-CXL  has  ample
otential  to  slow  the  progression  of  KC,7 and  studies  havePlease  cite  this  article  in  press  as:  Arance-Gil  Á,  et  al.  Epitheli
progressive  keratoconus:  3  years  of  follow-up.  J  Optom.  (2020
ompared  both  techniques  in  terms  of  the  effects  of  the
reatment.8--12
t
wHowever,  there  have  been  few  publications  to  date
hat  compared  both  techniques  taking  into  account  the
ocation  of  the  cone.  The  initial  corneal  shape  may  be
mportant  for  the  final  effect  of  the  treatment  since  CXL
ncreases  the  stability  of  the  corneal  structure  and  modifies
he  intrinsic  biomechanical  properties  of  corneal  colla-
en.
Our  work  sought  to  compare  both  treatments  after  3
ears  of  follow-up,  taking  into  account  the  patients’  age
nd  the  location  of  the  corneal  ectasia.
aterials and methods
his  was  a  comparative  prospective  study.  Both  the  epi-off
XL  and  the  TE-CXL  collagen  corneal  cross-linking  tech-
ique  were  evaluated.  The  patients  were  recruited  at
he  Novovision  Clinic  (Madrid,  Spain)  and  treated  by  the
ame  medical  team  using  the  same  surgical  and  post-
urgical  protocol.  Before  starting  the  study,  the  risks
nd  benefits  of  the  treatment  were  explained  to  the
atients,  and  informed  consent  was  obtained  from  all  of
he  subjects.  The  patients  were  free  to  leave  the  study
t  any  time.  The  study  was  conducted  in  compliance
ith  good  clinical  practice  guidelines,  the  institutional
eview  board  regulations,  and  the  tenets  of  the  Decla-
ation  of  Helsinki  revised  in  2013.13 Moreover,  the  study
as  approved  by  the  ethics  committee  of  the  Novovision
linic.
I-  Preoperative:
The  following  inclusion  criteria  were  taken  into  account:
ll  of  the  patients  exhibited  progressive  KC  according  to
opographic  data  (with  progression  defined  as  an  increase  of
 1  diopter  (D)  in  the  manifest  cylinder  and/or  an  increase
f  ≥  1  D  in  the  maximum  keratometry  observed  in  three
onsecutive  corneal  topographies  in  the  six  months  prior  to
he  study8)  that  were  grade  I  and  II  according  to  the  Amsler-
rumeich  classification  (central  keratometry  less  than  53  D,
achymetry  greater  than  400  m,  and  myopia  and/or  astig-
atism  of  8  D  or  less1) and  all  of  the  patients  were  older
han  12  years  of  age.  This  study  also  excluded  patients  with
ollagen  or  autoimmune  diseases,  severe  atopy,  or  other
cular  diseases,  as  well  as  individuals  who  were  pregnant
r  lactating.um-Off  vs.  transepithelial  corneal  collagen  crosslinking  in
),  https://doi.org/10.1016/j.optom.2020.07.005
ion  of  the  cone  was  taken  into  account,  including  patients
ith  central  and  paracentral  KC.
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Table  1  Variables  and  keratoconus  index  included  in  the  study.
Visuals  Corneal  aberrations  Previous  and  posterior
structure
Corneal  thickness
CDVA  Corneal  aberrations:
coma-like,  spherical-like
and  HOAs
Astigmatism  Pachymetry  at  the  apex
and  pachymetry  at  the
thinnest  point
Corneal densitometry  Keratometry:  K-max  and
meanK
Corneal  volume
Corneal  asphericty  (Q6,  Q8  and
Q10)
R min
Maximum  posterior  elevation
(6  mm)
Keratoconus  index:  ISV,  IVA,  KI,
CKI, IHA,  IHD
CDVA: corrected distance visual acuity; HOAs: higher-order aberrations; K-max: maximal keratometry; mean K: mean keratometry; Q6,
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central keratoconus index; IHA: index of height asymmetry; IHD: 
We  classified  the  KC  as  being  central  if  the  distance
between  the  point  of  least  corneal  thickness  and  the  center
of  the  cornea  was  0.7  mm  or  less,  while  the  KC  was  classi-
fied  as  paracentral  if  that  distance  was  between  0.7  and  2.1
mm.14
Patients  who  met  the  inclusion  criteria  were  assigned  to
one  of  the  two  treatment  groups,  i.e.,  the  epi-off  CXL  or
the  TE-CXL  group,  in  a  consecutive  manner  starting  with  the
TE-CXL  until  the  required  sample  was  reached.  II-  Intraop-
erative:
With  both  techniques,  the  same  UVA  emitter  device,
namely  a  CBM  X-linker  (CSO,  Florence,  Italy)  was  used  with
all  of  the  patients.
With  the  epi-off  CXL  technique,  the  central  8  mm  of
corneal  epithelium  was  removed  with  a  scarifier.  Drops
of  0.1%  RF  solution  were  then  instilled  with  20%  dextran
(Ricrolin®,  Florence,  Italy)  every  5  min  for  a  total  dura-
tion  of  30  min  to  saturate  the  corneal  stroma.  Using  a  slit
lamp,  yellow-colored  staining  could  then  be  seen  through-
out  the  corneal  layer  and  in  the  anterior  chamber.  A  UVA
light  source,  at  an  intensity  of  3  mW/cm2 and  a  wavelength
of  370  nm  (corresponding  to  the  maximum  absorption  of  the
RF)  was  then  applied  over  the  course  of  30  min  until  a total
radiation  exposure  of  5.4  J/cm2 was  achieved.3,4 During  the
treatment,  the  RF  was  instilled  every  5  min  and  a  topical
anesthetic  was  administered  every  15  min.  At  the  end  of  the
surgical  procedure,  a  single  drop  of  tobramycin  and  dex-
amethasone  (Tobradex®,  Barcelona,  Spain)  and  a  neutral
therapeutic  contact  lens  were  applied.
For  the  TE-CXL  technique,  the  procedure  was  performed
in  a  similar  manner  as  the  CXL  epi-off  technique,  althoughPlease  cite  this  article  in  press  as:  Arance-Gil  Á,  et  al.  Epitheli
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without  removal  of  the  corneal  epithelium,  using  a  TE-
RF  (Ricrolin  TE®)  composed  of  RF  0.1%,  15%  dextran,
trometamol,  and  ethylenediaminetetraacetic  acid  (EDTA).
The  remainder  of  the  process  was  carried  out  in  the  same
v
d
n
de; IVA: index of vertical asymmetry; KI: keratoconus index; CKI:
 of height decentration; R min: minimum radius of curvature.
anner,  and  there  was  no  need  for  a  therapeutic  contact
ens.
III-  Postoperative:
As postoperative  treatment  we  recommended
obramycin/Dexamethasone  1  mg/mL+3  mg/mL  eye  drops
tobradex®,  Barcelona,  Spain)  every  6  h  for  one  week  and
hen  Fluorometholone  0.1%  eye  drops  (FML®,  Madrid  Spain)
or  1  month  in  a  de-escalating  dose.
The  two  treatment  groups  were  compared  over  time  (6,
2,  24,  and  36  months)  taking  into  account  the  age  of  the
atients  and  the  location  of  the  KC  (central  or  paracentral).
n  all  of  the  follow-up  visits,  an  ophthalmological  examina-
ion  was  performed,  including  assessment  of  the  corrected
istance  visual  acuity  (CDVA),  topography,  and  corneal  aber-
ometry.  The  data  analyzed  in  this  work  were  obtained  using
 Pentacam  (Oculus,  Wetzlar,  Germany)  corneal  topogra-
her.
The  variables  evaluated  in  this  study  were  divided  into
hree  groups,  namely  the  visual  quality,  the  corneal  struc-
ure,  and  the  KC  index  visuals  variables,  corneal  aberrations,
revious  and  posterior  structure  and  corneal  thickness
Table  1)
tatistical  analysis
he  statistical  analysis  was  performed  using  SPSS  Statistics
3  software  (IBM,  Chicago,  Illinois,  USA).  A  descriptive  analy-
is  was  carried  out  for  all  of  the  study  variables,  thus  yielding
requency  tables  for  the  categorical  variables  (gender,  eye,
tc.)  and  tables  with  the  descriptors  of  the  continuousum-Off  vs.  transepithelial  corneal  collagen  crosslinking  in
),  https://doi.org/10.1016/j.optom.2020.07.005
ariables,  which  are  presented  as  means  and  the  standard
eviation,  and  ranges.  In  all  cases,  the  Kolmogorov-Smirnov
ormality  test  and  the  homogeneity  test  were  carried  out  to
etermine  the  statistical  approach  to  be  used  in  each  case.
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Fig.  1  Significant  changes  in  maximum  K  over  time  depending
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To  calculate  the  sample  size,  the  same  procedure  was  fol-
owed  as  in  the  CXL  study  performed  by  Raiskup-Wolf  et  al.15
hich  was  obtained  by  the  difference  between  the  expected
verage  change  of  the  maximum  K  after  treatment  (esti-
ated  at  -1.46  D)  and  the  acceptable  average  change  of
he  maximum  K  value  after  treatment  (estimated  by  Koller
t  al16 as  +1  D).  With  this  difference  of  -2.46  D,  and  taking
nto  account  a  standard  deviation  of  3.7615 the  sample  size
ecessary  for  an  alpha  of  0.05  and  a  beta  of  0.2  is  29  eyes
n  each  group17 Taking  into  account  a  possible  dropout  rate
uring  the  study  of  10%,  the  total  number  of  eyes  needed
as  estimated  to  be  32  per  group.
With  each  variable,  a  repeated  measures  ANOVA  (vari-
nce  analysis)  was  performed  to  study  the  differences
etween  both  groups  (epi-off  CXL/TE-CXL)  over  time  (6,
2,  24,  and  36  months)  according  to  the  location  of  the  KC
one  (central  or  paracentral)  and  age  as  main  effects,  as
ell  as  all  double  interactions.  A  statistical  significance  of
.05  was  established  (p  <  0.05).  The  results  are  presented  as
eans  ±  the  standard  deviation.
esults
he  study  included  64  eyes  from  46  patients  with  progressive
msler-Krumeich  grade  I  and  II  KC,  of  which  31  eyes  were
reated  with  epi-off  CXL  and  33  with  TE-CXL,  with  a  mean
ge  of  19.90  ±  5.7  years  (17.82−21.99  years)  and  25.33  ±  6.8
ears  (22.92--27.75  years),  respectively.
Table  2  shows  the  patient  distribution  according  to  the
urgical  technique,  the  degree  of  KC,  and  the  location  of
he  ectasia.
The  baseline  characteristics  of  each  of  the  variables  to
e  studied  in  both  treatment  groups  and  their  degree  of
omogeneity  are  detailed  in  Table  3.
The  groups  were  not  homogeneous  in  terms  of  age  or
he  maximum  K  value,  as  the  patients  in  the  group  being
reated  with  epi-off  CXL  tended  to  be  younger  and  have
ore  advanced  KC.  Since  age  is  an  important  factor  that
eeds  to  be  taken  into  account  with  this  pathology,  it  was
ncluded  as  a  covariate  in  the  statistical  method.
After  the  collagen  corneal  CXL  procedure,  significant
hanges  in  the  corrected  distance  visual  acuity  (CDVA)
nd  asphericity  at  6  mm  (Q6)  were  found  over  time  that
epended  on  the  location  of  the  cone.  The  CDVA  improved
oth  for  those  with  a  central  KC  (mean  of  -0.2  log  MAR)  and
ith  a  paracentral  KC  (mean  of  -0.07  log  MAR)  (p-value  <
.05;  one-way  ANOVA  for  repeated  measures).  The  aspheric-
ty  at  6  mm  improved  for  those  with  a  central  KC,  (p-value
 0.05;  one-way  ANOVA  for  repeated  measures),  while  it
emained  stable  with  a  paracentral  KC  (Table  4)
Significant  differences  were  found  between  both  treat-
ents  over  time  in  terms  of  the  coma-like  aberration,
igher-order  aberrations  (HOAs),  densitometry,  maximum
 (Fig.  1),  asphericity  at  8  mm  and  10  mm  (Q8,  Q10),
achymetry  at  the  apex,  pachymetry  at  the  thinnest  point,
ndex  of  surface  variance  (ISV),  and  the  minimum  radius
f  curvature  (R  min)  (p-value  <  0.05;  one-way  ANOVA  forPlease  cite  this  article  in  press  as:  Arance-Gil  Á,  et  al.  Epitheli
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epeated  measures).  After  epi-off  CXL,  there  was  improve-
ent  in  the  coma-like  aberration,  HOAs,  Q8,  Q10,  and  ISV
alues,  while  after  TE-CXL,  these  variables  remained  sta-
le.  Additionally,  the  changes  in  densitometry  and  corneal
c
t
c
tn the  treatment  used  (epi-off  CXL  and  TE-CXL).  1-  preopera-
ive,  2-  6  months,  3-12  months,  4-  24  months  and  5-36  months.
achymetry  were  significant  after  epi-off  CXL,  remaining
table  after  TE-CXL,  and  the  variables  of  maximum  K  and  the
nterior  minimum  radius  remained  stable  with  both  treat-
ents  (Table  5).
We  did  not  have  any  complications  with  any  of  the  tech-
iques.
iscussion
ince  Wollesak  introduced  the  crosslinking  of  corneal  col-
agen  (CXL)  in  the  treatment  of  QC  in  2003,3 it  has  been
hown  to  be  effective  in  slowing  down  or  stopping  the
rogression  of  QC.4,5 However,  the  removal  of  the  corneal
pithelium  remains  controversial.6,17,18 On  the  other  hand,
E-CXL  is  developed  to  avoid  the  adverse  effects  caused  by
he  removal  of  the  corneal  epithelium.7 And  in  recent  years,
everal  clinical  trials  have  been  designed  to  compare  the
herapeutic  effects  between  the  two  methods.8--12
Our  study  sought  to  compare  both  treatments  over  a
hree-year  period,  taking  into  account  the  age  of  the
atients  and  the  location  of  the  corneal  ectasia.
One  of  the  drawbacks  of  our  study  was  the  lack  of  homo-
eneity  in  the  groups  of  patients  treated  with  the  different
urgical  techniques,  since  the  baseline  characteristics  of
atients  treated  with  TE-CXL  comprised  less  advanced  KC
han  was  the  case  for  patients  treated  with  epi-off  CXL.
ertain  variables  present  clinically  different  values  in  the
reoperative  period.  This  is  justified  by  the  allocation  cri-
eria  for  each  epi-off  CXL  or  TE-CXL  group.  As  this  was  not
 clinical  trial,  the  study  was  not  randomized  and  it  fol-
owed  the  protocol  for  the  assigned  allocation  of  the  private
linic  in  which  the  study  was  conducted.  As  can  be  seen  inum-Off  vs.  transepithelial  corneal  collagen  crosslinking  in
),  https://doi.org/10.1016/j.optom.2020.07.005
he  tables,  the  values  of  the  variables  that  exhibited  signifi-
ant  differences  in  the  preoperative  period  were  higher  than
hose  performed  with  epi-off  CXL.  This  indicates  a  greater
ARTICLE IN PRESS+ModelOPTOM-364; No. of Pages 10
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Table  2  The  number  of  eyes  treated  with  CXL  epi-off  versus  CXL  TE  according  to  the  degree  and  the  location  of  the  KC.
Type  of  CXL  Grade  I  Grade  II  Total  Central  KC  Paracentral  KC
Epi-off  CXL  17  14  31  13  18
TE CXL  23  10  33  6  27
Total 40 24  64  19  45
p-value =  0.220 p-value  =  0.038
CXL: corneal crosslinking; KC: keratoconus.
Chi-square test results of Grade I/II between two groups of treatment, p-value = 0.220.
Chi-square test results of central/paracentral kc between two groups of treatment, p-value =.
0.038.
Table  3  Baseline  characteristics  of  the  study  groups.
Variables  epi-off  CXL  TE  CXL  p-value
Age,  years  (rank)  19.90  ±  5.7(17.82−21.99)  25.33  ±  6.8(22.92−24)  0.001*
CDVA (log  MAR)  0.1635  ±  0.13  0.0981  ±  0.21  0.179
Coma-Like (m)  3.27  ±  1.72  2.19  ±  1.49  0.090
Spherical-like  (m)  0.48  ±  0.42  0.47  ±  0.47  0.984
HOAs (m)  3.5  ±  1.7  2.4  ±  1.3  0.005*
Corneal densitometry  27.95  ±  5.37  22.42  ±  3.41  0.001*
Astigmatism  (D)  4.12  ±  2.4  3.13  ±  1.5  0.050
K-max (D)  56.65  ±  5.9  51.95  ±  5.7  0.020*
Mean K  (D)  47.64  ±  3.2  45.49  ±  3  0.070
Q6 −0.99  ±  072  −0,56  ±  0.62  0.012*
Q8 −0.82  ±  0.36  −0.54  ±  0.34  0.020*
Q10 −0.70  ±  0.36  −0.60  ±  0.22  0.170
Maximum posterior  elevation  (m)  54.39  ±  25.87  48.88  ±  30.39  0.439
Pachymetry  at  the  apex  (m)  484.52  ±  32.47  499.18  ±  38.02  0.103
Pachymetry  at  the  thinnest  point  (m)  475.35  ±  33.73  483.79  ±  43.59  0.392
Corneal volume  (mm3)  58.13  ±  3.82  57.94  ±  3.66  0.838
ISV 91.26  ±  34.29  72.91  ±  37.31  0.045*
IVA 1.03 ±  0.56  0.82  ±  0.49  0.086
KI 1.25  ±  0.12  1.18  ±  0.11  0.012*
CKI 1.06  ±  0.04  1.04  ±  0.05  0.063
IHA 41.50  ±  28.08 23.12  ±  21.41  0.007*
IHD 0.11  ±  0.06 0.09  ±  0.06 0.125
R min  (mm) 6.02  ±  0.63 6.56  ±  0.67  0.002*
CDVA: corrected distance visual acuity; HOAs: higher-order aberrations; K-max: maximal keratometry; mean K: mean keratometry; Q6,
Q8, Q10: asphericity at 6 mm,8 mm and 10 mm; ISV: index of surface variance; IVA: index of vertical asymmetry; KI: keratoconus index;
D: in
t
v
(
(
r
t
b
t
t
r
w
tCKI: central keratoconus index; IHA: index of height asymmetry; IH
* p < 0.05; one-way ANOVA for independent measure.
degree  of  development  of  keratoconus  in  those  undergoing
this  procedure.
Age  did  not  influence  the  variables  studied,  except  for
the  index  of  height  asymmetry  (IHA).
Both  of  the  surgical  techniques  resulted  in  stabilization  of
the  CDVA  during  the  36-month  follow-up,  which  is  similar  to
the  results  obtained  in  a  number  of  other  studies,19 although
most  of  the  comparative  studies  to  date  have  reported
improvement  with  both  techniques.8--12
CDVA  improved  in  patients  with  central  and  paracentral
KC  treated  with  corneal  CXL,  with  significant  differences
between  them  over  time,  with  a  greater  increase  in  centralPlease  cite  this  article  in  press  as:  Arance-Gil  Á,  et  al.  Epitheli
progressive  keratoconus:  3  years  of  follow-up.  J  Optom.  (2020
KC.
The  two  most  significant  indicators  of  improvement  in
vision  after  corneal  CXL  were  the  preoperative  values  of  low
CDVA  (≤  20/40)  and  high  K-max  values  (≥  55  D).1,8,20,21 In
C
C
hdex of height decentration; R min: minimum radius of curvature.
he  current  study,  the  central  KCs  exhibited  lower  average
alues  for  the  preoperative  CDVA,  with  higher  K-max  values
0.25  ±  0.04  log  MAR  and  56.6  D)  compared  to  paracentral  KC
0.1  ±  0.2  log  MAR  and  53.84  D),  which  could  explain  these
esults.  The  greater  improvement  in  the  CDVA  in  the  cen-
ral  cones  is  in  accordance  with  what  has  been  published
y  other  authors,22,23 and  this  may  be  due  to  the  fact  that
he  central  area  is  closer  to  the  radiation  of  the  CXL,  so
he  intensity  of  radiation  is  higher  than  in  the  paracentral
egion,  plus  the  depth  does  not  appear  to  be  homogeneous
ithin  the  treatment  area,  exhibiting  a  decrease  towards
he  periphery  of  the  cornea.24um-Off  vs.  transepithelial  corneal  collagen  crosslinking  in
),  https://doi.org/10.1016/j.optom.2020.07.005
The  coma-like  and  HOA  values  remained  stable  after  TE-
XL,  while  there  was  a  significant  improvement  after  epi-off
XL  despiste  the  fact  that  patients  treated  with  epi-off  CXL
ad  a  more  advanced  KC.  This  may  be  explained  by  a  greater
ARTICLE IN PRESS+ModelOPTOM-364; No. of Pages 10
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Table  4  The  values  for  the  CDVA  and  Q6  after  the  corneal  CXL  taking  into  account  the  location  of  the  cone  over  time.
Variable  Keratocons
location
Preop  6m  12m  24m  36m  inter-group
p-value
intra-group
p-value**
CDVA
(log  mar)
Central  KC
Paracentral
KC
0.25  ±  0.04
0.11  ±  0.02
0.16  ±  0.05
0.11  ±  0.03
0.04  ±  0.05
0.09  ±  0.03
0.06  ±  0.04
0.04  ±  0.03
0.05  ±  0.04
0.03  ±  0.02
0.001*  0.001*
0.057
Q6 Central  KC
Paracentral
KC
−1.59  ±  0.20
−0.58  ±  0.13
−1.69  ±  0.20
−0.69  ±  0.13
−1.47  ±  0.18
−0.60  ±  0.11
−1.40  ±  0.18
−0.58  ±  0.12
−1.29  ±  0.19
−0.59  ±  0.12
0.04*  0.599
1.000
CDVA: corrected distance visual acuity; Q6: asphericity at 6 mm;  p: statistical change at month 36 compared with preoperative data;
one-way ANOVA for repeated measures.
ths).
onths
d
c
T
b
e
d
f
C
i
2
s
w
t
s
o
c
d
c
i
C
i
b
h
t
o
e
h
b
i
a
s
K
l
o
a
K
b
t
s
C
p
d
1
w
w
p
n
C
g
t
a
a
r
m
T
w
c
t
p
p
t
s
o
a
t
a
C
I
f
i
k
s
k
t
e
t
t
tInter-group p-value (preoperative inter-group difference: 36 mon
intra-group p-value ** (preoperative intra-group difference: 36 m
egree  of  regularization  of  the  corneal  surface  due  to  more
ompaction  of  the  collagen  fibers  following  this  technique.
he  spherical  aberration  and  coma  values  remained  sta-
le  with  both  techniques  in  the  comparative  study  by  Rossi
t  al.25 The  random  controlled  trial  by  Stojanovic  et  al.26
id  find  significant  changes  in  HOAs  during  the  12-month
ollow-up  in  all  of  the  groups  and  between  them.
The  densitometry  readings  remained  stable  after  TE-
XL,  while  after  epi-off  CXL  there  was  a  significant
ncrease  after  6  months,  going  from  an  initial  average  of
7.6  ±  1.4--40.6  ±  3.2,  only  to  decrease  at  each  of  the  sub-
equent  checkup  examinations,  with  no  significant  change
ith  respect  to  the  preoperative  values  from  12  months  to
he  end  of  the  study.  Similar  results  were  obtained  by  Green-
tein  et  al.6 The  increases  may  be  associated  with  the  depth
f  CXL  in  the  stroma,  as  well  as  with  the  amount  of  kerato-
yte  loss,  activated  keratocytes,  inflammation  of  the  stroma
ue  to  changes  in  pressure,  interactions  of  proteoglycans-
ollagen,  hydration  of  glycosaminoglycans,  and  an  increase
n  the  diameter  of  collagen  fibers  of  12.2%  (3.96  nm).27
The  K-max  is  an  indicator  of  the  stability  of  the  KC  after
XL.  Progression  of  the  KC  is  generally  defined  as  an  increase
n  the  K-max  of  1  D  or  more  at  6,8 12,28 or  2429 months.  With
oth  techniques,  the  K-max  values  remained  stable,  thus
alting  further  KC  progression  and  taking  into  account  that
he  patients  with  more  advanced  KC  were  treated  with  epi-
ff  CXL,  which  is  similar  to  what  was  noted  by  Stojanovic
t  al.26 and  Cifariello  et  al.11 Most  of  the  studies  to  date
ave  reported  a  decrease  or  stabilization  of  the  K-max  with
oth  techniques.10,19,25 However,  Kocak  et  al.30 obtained  an
mprovement  in  the  K-max  after  epi-off  CXL  and  a  worsening
fter  TE-CXL.
One  simple  method  to  quantitatively  describe  the  corneal
hape  is  the  corneal  asphericity.  The  Q6  values  of  the  central
C  became  less  negative  and  the  Q8  and  Q10  values  became
ess  negative  after  epi-off  CXL  in  this  study.  Therefore,  epi-
ff  CXL  regularized  the  corneal  surface  more  than  TE-CXL,
nd  it  also  improved  more  in  central  KC  than  in  paracentral
C.  This  improvement  in  the  Q  values  following  CXL  may
e  due  to  compaction  of  the  collagen  fibers  that  renders
31Please  cite  this  article  in  press  as:  Arance-Gil  Á,  et  al.  Epitheli
progressive  keratoconus:  3  years  of  follow-up.  J  Optom.  (2020
he  cornea  surface  more  regular.  Sedaghat  et  al. reported
tabilization  of  corneal  asphericity  values  following  epi-off
XL  after  12  months  of  follow-up.
t
u).
The  groups  were  homogeneous  both  in  terms  of
achymetry  at  the  corneal  apex  and  at  the  thinnest  point,
ecreasing  in  the  first  few  months  and  then  increasing  from
2  months  to  the  end  of  the  study  following  epi-off  CXL
hile  remaining  stable  after  TE-  CXL.  This  is  similar  to
hat  has  been  found  in  a  number  of  studies,6although  other
ublications,19,25 have  reported  stability  with  both  tech-
iques.  The  reduction  in  corneal  thickness  following  epi-off
XL  could  be  a  consequence  of  several  factors  such  as  colla-
en  fiber  compaction,  stromal  dehydration,  cell  death  due
o  apoptosis  of  keratocytes  after  exposure  to  UVA  light,
lterations  in  the  scarring  and  the  epithelial  distribution,
nd  its  subsequent  increase  could  be  a  consequence  of  the
epopulation  of  keratocytes  that  takes  place  after  the  sixth
onth.32 Failure  to  find  these  thickness  changes  following
E-CXL  could  indicate  less  of  a  structural  effect.8
Following  epi-off  CXL,  the  ISV  improved  significantly,
hile  remaining  stable  following  TE-CXL,  with  a  statisti-
ally  significant  difference  with  both  treatments  over  the
ime  period  that  was  studied.  With  both  techniques,  the
revious  minimum  radius  remained  stable  during  the  study
eriod,  although  there  was  a  significant  difference  with  both
echniques  over  time.  Magli  et  al.19 observed  a  statistically
ignificant  decrease  in  the  IHA  with  both  techniques,  with-
ut  finding  differences  between  them.  C¸erman  et  al.8 found
 significant  decrease  in  the  ISV  and  IVA  (vertical  asymme-
ry  index)  with  both  treatments.  The  KI  (KC  index)  decreased
fter  epi-off  CXL,  while  it  remained  stable  after  TE-CXL.  The
KI  (central  KC  index)  remained  stable  in  both  groups.  The
HA  did  not  change  after  epi-off  CXL,  although  it  increased
ollowing  TE-CXL.  The  IHD  (index  of  height  decentration)
ncreased  in  both  groups.  Today,  to  assess  the  evolution  of
eratoconus  without  surgery,  several  indices  could  be  used,
uch  as  the  D  index,  the  index  for  height  symmetry  or  the
eratoconus  progression  index  (KPI),  which  have  been  shown
o  be  effective.33 Likewise,  the  analysis  of  topography  and
pithelial  thickness  could  be  of  interest  to  assess  the  effects
hat  the  different  types  of  CXL  have  on  this  corneal  layer  and
heir  responsibility  for  the  changes  found  after  the  different
ypes  of  treatmentum-Off  vs.  transepithelial  corneal  collagen  crosslinking  in
),  https://doi.org/10.1016/j.optom.2020.07.005
In our  study,  no  significant  differences  were  found  in
erms  of  astigmatism,  posterior  elevation,  or  corneal  vol-
me.
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Table  5  The  values  for  coma-like,  HOAs,  densitometry,  K-max,  Q8,  Q10,  pachymetry  at  the  apex,  pachymetry  at  the  thinnest  point,  ISV,  and  anterior  minimum  radius  taking
into account  both  techniques  over  time.
Variable Type  of  CXL preoperative  6m  12m  24m  36m  inter-group
p-value
intra-group
p-value  **
Coma-like  Epi-off  CXL
TE  CXL
3.39  ±  0.38
1.35  ±  0.47
3.16  ±  0.38
1.35  ±  0.47
3.14  ±  0.37
1.22  ±  0.46
2.99  ±  0.32
1.32  ±  0.4
2.79  ±  0.29
1.41  ±  0.37
0.038*
0.033*
1.000
HOAs Epi-off  CXL
TE CXL
3.78  ±  0.37
2.04  ±  0.45
3.54  ±  0.37
1.70  ±  0.45
3.39  ±  0.35
1.64  ±  0.43
3.24  ±  0.31
1.67  ±  0.39
2.83  ±  0.27
1.75  ±  0.33
0.036*
0.005*
1.000
Densitometry  Epi-off  CXL
TE CXL
27.58  ±  1.41
23.27  ±  1.71
40.60  ±  3.20
22.24  ±  3.89
31.40  ±  1.59
22.29  ±  1.93
28.63  ±  1.31
21.29  ±  1.38
28.04  ±  2.11
20.02  ±  2.57
0.003*
1.000
1.000
K-max Epi-off  CXL
TE  CXL
58.49  ±  1.52
53.33  ±  1.82
58.82  ±  1.66
53.49  ±  1.99
58.11  ±  1.72
54.11  ±  2.06
57.59  ±  1.62
53.93  ±  1.94
57.68  ±  1.62
53.93  ±  1.94
0.038*
1.000
1.000
Q8 Epi-off  CXL
TE  CXL
−0.91  ±  0.06
−0.76  ±  0.08
−0.96  ±  0.08
−0.81  ±  0.11
−0.86  ±  0.07
−0.77  ±  0.09
−0.83  ±  0.07
−0.75  ±  0.09
−0.76  ±  0.07
−0.79  ±  0.10
0.049*
0.037*
1.000
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Table  5  (Continued)
Variable  Type  of  CXL  preoperative  6m  12m  24m  36m  inter-group
p-value
intra-group
p-value  **
Q10  Epi-off  CXL
TE  CXL
−0.77  ±  0.05
−0.68  ±  0.06
−0.8  ±  0.05
−0.7  ±  0.06
−0.78  ±  0.05
−0.75  ±  0.06
−0.75  ±  0.05
−0.78  ±  0.07
−0.64  ±  0.06
−0.71  ±  0.08
0.049*
0.088
1.000
Pachymetry
at the  apex
Epi-off  CXL
TE CXL
485.25  ±  7.42
492.93  ±
10.16
461.29  ±  8.40
490.41  ±
11.49
475.91  ±  8.41
492.34  ±
11.51
479.53  ±  8.07
487.88  ±
11.05
482.3  ±  8.95
485.94  ±  12.25
0.005*
1.000
1.000
Pachymetry
at the
thinnest
point
Epi-off  CXL
TE  CXL
476.35  ±  8.34
481  ±  11.42
449.34  ±  8.61
482.46  ±
11.79
463.41  ±  8.55
481.72  ±
11.71
461.72  ±  8.94
47,419  ±
12.25
468.7  ±  8.9
47,479  ±  12.19
0.003*
0.679
1.000
ISV Epi-off  CXL
TE  CXL
95.49  ±  8.07
62.24  ±  11.05
94.99  ±  8.09
59.93  ±  11.08
91.48  ±  7.79
58.59  ±  10.67
89.68  ±  7.53
60.17  ±  10.31
87.04  ±  7.46
62.34  ±  10.21
0.049*
0.035*
1.000
R min  Epi-off  CXL
TE  CXL
5.82  ±  0.14
6.41  ±  0.19
5.8  ±  0.15
6.41  ±  0.2
5.87  ±  0.15
6.37  ±  0.21
5.92  ±  0.15
6.36  ±  0.2
5.93  ±  0.15
6.37  ±  0.2
0.05
0.795
1.000
HOAs: higher-order aberrations; K-max: maximal keratometry; Q8, Q10: asphericity at 8 mm,10 mm;  ISV: index of surface variance; R min: minimum radius of curvature; P: statistical
change at month 36 compared with preoperative data. One-way ANOVA for repeated measures.
Inter-group p-value (preoperative inter-group difference: 36 months).
Intra-group p-value ** (preoperative intra-group difference: 36 months).
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Even  though  the  most  frequent  postoperative
complications  after  the  epi-off  CXL  technique  are
infection,34 persistent  corneal  edema35 and  the  need
for  keratoplasty,36 our  study  did  not  reveal  a  difference
between  the  group  treated  with  epi-off  CXL  and  treatment
with  transepithelial  CXL,  as  in  other  works.8,25 This  may
be  due  to  the  fact  that  patients  were  treated  in  the  early
stages  of  keratoconus  and  the  sample  size  was  not  too  big,
which  suggests  that  a  larger  number  of  subjects  may  be
needed  to  be  able  to  compare  the  rate  of  postoperative
complications  between  CXL  techniques
In  conclusion,  epi  off-CXL  was  more  effective  from  the
point  of  view  of  the  aberometric  and  morphological  prop-
erties  of  the  cornea  although  both  techniques  halted  and
stabilized  the  progression  of  KC,  epi-off  CXL  was  more
effective.  Additionally,  following  the  corneal  CXL  technique,
there  was  a  greater  degree  of  regularization  of  the  corneal
surface  and,  therefore,  a  greater  degree  of  improvement  in
the  visual  acuity  that  was  corrected  much  more  in  central
KC  than  in  paracentral  KC.
Financial disclosure
None  of  the  authors  has  a  financial  or  proprietary  interest  in
any  material  or  method  mentioned.
Conflict of interest
The  authors  declare  that  there  is  no  conflict  of  interest.
References
1. O’Brart DP, Kwong TQ, Patel P, McDonald RJ, O’Brart NA. Long-
term follow- up of riboflavin/ultraviolet A (370 nm) corneal
collagen cross-linking to halt the progression of keratoconus.
Br J Ophthalmol. 2013;97:433--437.
2. Fátima T, Acharya MC, Mathur U, Barua P. Demographic profile
and visual rehabilitation of patients with keratoconus attend-
ing contact lens clinic at a tertiary eye care center. Contact
Lens Anterior Eye. 2010;33:19--22.
3. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-
induced collagen crosslinking for the treatment of keratoconus.
Am J Ophthalmol. 2003;135:620--627.
4. Li W,  Wang B. Efficacy and safety of transepithelial corneal
collagen crosslinking surgery versus standard corneal collagen
crosslinking surgery for keratoconus: A meta-analysis of ran-
domized controlled trials. BMC Ophthalmol. 2017;17:262.
5. Mazzotta C, Traversi C, Baiocchi S, et al. Corneal collagen
cross-linking with riboflavin and ultraviolet A light for pediatric
keratoconus: Ten-year results. Cornea.  2018;37:560--566.
6. Greenstein SA, Fry KL, Bhatt J, Hersh PS. Natural history of
corneal haze after collagen crosslinking for keratoconus and
corneal ectasia: Scheimpflug and biomicroscopic analysis. J
Cataract Refract Surg. 2010;36:2105--2114.
7. Caporossi A, Mazzotta C, Paradiso AL, Baiocchi S, Marigliani D,
Caporossi T. Transepithelial corneal collagen crosslinking for
progressive keratoconus: 24-month clinical results. J Cataract
Refract Surg. 2013;39:1157--1163.
8. C¸erman E, Toker E, Oxarslan Ozcan D. Transepithelial versusPlease  cite  this  article  in  press  as:  Arance-Gil  Á,  et  al.  Epitheli
progressive  keratoconus:  3  years  of  follow-up.  J  Optom.  (2020
epithelium-off crosslinking in adults with progressive kerato-
conus. J Cataract Refract Surg. 2015;41:1416--1425.
9. Soeters N, Wisse RPL, Godefrooij DA, Imhof SM, Tahzib NG.
Transepithelial versus epithelium-off corneal crosslinking for PRESS
n  progressive  keratoconus:  3  years  of  follow-up  9
the treatment of progressive keratoconus: A randomized con-
trolled trial. Am J Ophthalmol. 2015;159:821--828.
10. Rush SW, Rush RB. Epithelium-off versus transepithelial corneal
crosslinking for progressive corneal ectasia: A randomised and
controlled trial. Br J Ophthalmol. 2017;101:503--508.
11. Cifariello F, Minicucci M, Di Renzo F, et al. Epi-off versus epi-
on corneal collagen cross-linking in keratoconus patients: A
comparative study through 2-year follow-up. J Ophthalmol.
2018;29:4947983.
12. Wen D, Song B, Li Q, et al. Comparison of epithelium-off
versus transepithelial corneal collagen cross-linking for ker-
atoconus: A systematic review and meta-analysis. Cornea.
2018;37:1018--1024.
13. World Medical Association. World Medical Association Dec-
laration of Helsinki: Ethical principles for medical research
involving human subjects. Jama. 2013;310:2191--2194.
14. Alfonso JA, Lisa C, Fernández-Vega L, Poo A, Madrid D. Ker-
atoconus classification based on clinical phenotypes. In: Del
Buey MA, Peris C, eds. Biomechanics and corneal architecture.
Barcelona. Elsevier: SECOIR; 2014:165--184.
15. Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Colla-
gen crosslinking with riboflavin and ultraviolet-A light in
keratoconus: Long-term results. J Cataract Refract Surg.
2008;34:796--801.
16. Koller T, Mrochen M, Seiler T. Complication and failure
rates after corneal crosslinking. J Cataract Refract Surg.
2009;35:1358--1362.
17. Wittes J. Sample size calculations for randomized controlled
trials. Epidemiol Rev. 2002;24:39--53.
18. Koppen C, Wouters K, Mathysen D, Rozema J, Tassignon MJ.
Refractive and topographic results of benzalkonium chloride-
assisted transepithelial crosslinking. J Cataract Refract Surg.
2012;38:1000--1005.
19. Magli A, Forte R, Tortori A, Capasso L, Marsico G, Piozzi E.
Epithelium-off corneal collagen cross-linking versus transep-
ithelial cross-linking for pediatric keratoconus. Cornea.
2013;32:597--601.
20. Badawi AE, Abou Samra WA, El Ghafar AA. Predictive factors
of the standard cross-linking outcomes in adult keratoconus:
One-year follow-up. J Ophthalmol. 2017;2017:4109208.
21. Kasai K, Kato N, Konomi K, Shinzawa M, Shimazaki J. Flattening
effect of corneal cross-linking depends on the preopera-
tive severity of keratoconus. Medicine (Baltimore). 2017;
96:e8160.
22. Greenstein SA, Fry KL, Hersh PS. Effect of topographic cone
location on outcomes of corneal collagen cross-linking for
keratoconus and corneal ectasia. J Refract Surg. 2012;28:
397--405.
23. Tian M, Ma P, Zhou W, Feng J, Mu G. Outcomes of corneal
crosslinking for central and paracentral keratoconus. Medicine
(Baltimore). 2017;96:e6247.
24. Greenstein SA, Hers Ps. Characteristics influencing outcomes
of corneal collagen crosslinking for keratoconus and ectasia:
Implications for patient selection. J Cataract Refract Surg.
2013;39:1133--1140.
25. Rossi S, Orrico A, Santamaría C, et al. Standard versus
trans-epithelial collagen cross-linking in keratoconus patients
suitable for standard collagen crosslinking. Clin Ophthalmol.
2015;18:503--509.
26. Stojanovic A, Zhou W,  Utheim TP. Corneal collagen cross-
linking with and without epithelial removal: A contralateral
study with 0.5% hypotonic riboflavin solution. Biomed Res Int.
2014;2014:619398.
27. Mazzotta C, Balestrazzi A, Traversi C, et al. Treatment of pro-
gressive keratoconus by riboflavin-UVA- induced cross-linkingum-Off  vs.  transepithelial  corneal  collagen  crosslinking  in
),  https://doi.org/10.1016/j.optom.2020.07.005
of corneal collagen: Ultrastructural analysis by Heidelberg
retinal tomograph II in vivo confocal microscopy in humans.
Cornea. 2007;26:390--397.
 IN+ModelO
1
atoconus. Am J Ophthalmol. 2012;154:922--926.
36. Shalchi Z, Wang X, Nanavaty MA. Safety and efficacy of epithe-
lium removal and transepithelial corneal collagen crosslinkingARTICLEPTOM-364; No. of Pages 10
0  
28. Hersh PS, Greenstein SA, Fry KL. Corneal collagen crosslink-
ing for keratoconus and corneal ectasia: One-year results. J
Cataract Refract Surg. 2011;37:149--160.
29. Leccisotti A, Islam T. Transepithelial corneal collagen cross-
linking in keratoconus. J Refract Surg. 2010;26:942--948.
30. Kocak I, Aydin A, Kaya F, Koc H. Comparison of transepithelial
corneal collagen crosslinking with epithelium-off crosslinking
in progressive keratoconus. J Fr Ophtalmol.  2014;37:371--376.
31. Sedaghat M, Bagheri M, Ghavami S, Bamdad S. Changes in
corneal topography and biomechanical properties after colla-
gen cross-linking for keratoconus: 1-year results. Middle EastPlease  cite  this  article  in  press  as:  Arance-Gil  Á,  et  al.  Epitheli
progressive  keratoconus:  3  years  of  follow-up.  J  Optom.  (2020
Afr J Ophthalmol. 2015;22:212--219.
32. Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety
of UVA-riboflavin cross-linking of the cornea. Cornea.
2007;26:385--389. PRESS
Á.  Arance-Gil  et  al.
33. Shajari M, Steinwender G, Herrmann K, et al. Evaluation of
keratoconus progression. Br J Ophthalmol. 2019;103:551--557.
34. Abbouda A, Abicca I, Alio JL. Infectious keratitis following
corneal crosslinking: A systematic review of reported cases:
Management, visual outcome, and treatment proposed. Semin
Ophthalmol. 2016;31:485--491.
35. Sharma A, Nottage JM, Mirchia K, Sharma R, Mohan K, Nirankari
VS. Persistent coneal edema after collagen crosslinking for ker-um-Off  vs.  transepithelial  corneal  collagen  crosslinking  in
),  https://doi.org/10.1016/j.optom.2020.07.005
for keratoconus. Eye (Lond).  2015;29:15--29.
